Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | August 29, 2014

If ANDA is Silent on Infringement, then Infringement is Assessed Based on the Product Likely to Be Sold; Courts Have Discretion to Consider Post-Trial ANDA Amendments

Blog | August 28, 2014

Double-Patenting May Apply Whenever Two Patents Have Different Expiration Dates; Later-Expiring Patent to a Species Was Invalid Where Earlier-Expiring Patent Disclosed Small Genus and the Utility Claimed in the Later Patent

Blog | August 28, 2014

District Court Properly Clarified Claim Construction Post-Verdict to Require Method Steps Be Performed In a Particular Order to Avoid Rendering One Step Superfluous

Blog | August 26, 2014

N.D. Ga. Rejects Indefiniteness Argument under Nautilus v. Biosig

Blog | August 20, 2014

Federal Circuit Affirms Inequitable Conduct Finding in Apotex v. UCB

Blog | August 12, 2014

IPR's and the Hatch-Waxman 30-Month Stay of FDA Approval

Blog | August 11, 2014

When Sleeping Dogs Aren't Allowed to Lie

Blog | August 08, 2014

Hatch-Waxman Actions: Who Do You (Can You) Sue?

Blog | August 05, 2014

Notice Of Invalidity Position Insufficient To Preserve Right To Post-Trial JMOL

Blog | August 01, 2014

Price of SSPPU is No Proxy for Value of Invention

Blog | July 18, 2014

AIA revisions to false marking statute not unconstitutional

Blog | July 17, 2014

Federal Circuit orders district court to stay litigation pending CBM review